by University of Basel Post-hoc analysis of the drug effect on the primary outcome per cognitive baseline group, violin plots. Credit: Molecular Psychiatry (2024). DOI: 10.1038/s41380-024-02820-1 Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in mental health conditions like...
Tag: <span>Multiple sclerosis</span>
Post
Combining cell therapy with approved drug shows promise for treating multiple sclerosis
October 2, 2024 by Josep Carreras Leukaemia Research Institute Multiple sclerosis (MS) is a long-term disease where the immune system mistakenly attacks the protective layer around nerve cells, known as the myelin sheath. This leads to nerve damage and worsening disability. Current treatments, like immunosuppressants, help reduce these harmful attacks but also weaken the overall...
Post
Multiple sclerosis symptoms at onset linked to long-term disability
News Release 24-Sep-2024 New study reveals blurry vision and sphincter dysfunction as key predictors of functional outcomes in MS patients Peer-Reviewed PublicationGenomic Press In a significant advance for multiple sclerosis (MS) research, a new study has uncovered a potential link between certain initial symptoms and long-term disability outcomes. The research, published in the latest issue...
Post
Key biomarkers identified for predicting disability progression in multiple sclerosis
September 19, 2024 by European Committee for Treatment and Research in Multiple Sclerosis Credit: Pixabay/CC0 Public DomainA study presented at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening in multiple sclerosis (MS). The breakthrough research has the potential to transform treatment strategies for millions of MS patients worldwide, paving the way for...
Post
Early treatment significantly reduces long-term disability in children with multiple sclerosis, new study finds
September 17, 2024 by European Committee for Treatment and Research in Multiple Sclerosis Credit: Unsplash/CC0 Public DomainNew research presented today at European Committee for Treatment and Research in Multiple Sclerosis 2024 reveals that initiating monoclonal antibody therapy during childhood, rather than delaying treatment until early adulthood, significantly reduces long-term disability in multiple sclerosis (MS) patients....
Post
Some people with MS may need earlier, higher-dose meds, study shows
September 18, 2024 by Dennis Thompson Early, aggressive treatment of brain lesions caused by multiple sclerosis could help ward off faster decline in patients, a new study finds. Such treatment could prevent or potentially cure paramagnetic rim lesions (PRL), areas of chronic brain inflammation that are linked to more rapid deterioration in MS patients, researchers...
Post
Kessler Foundation scientists publish protocol for combining aerobic exercise and cognitive rehabilitation in multiple sclerosis
News Release 3-Sep-2024 Novel approach to treating impairments in MS particularly focuses on new learning and memory deficits Peer-Reviewed PublicationKessler Foundation image: Lead Author Carly L.A. Wender, PhD, research scientist at Kessler Foundation explored a novel combinatory approach to treating cognitive impairments in MS, particularly focusing on new learning and memory deficits. Credit: Kessler Foundation...
Post
Nutrition program for people with multiple sclerosis shows promising results
September 10, 2024 by Curtin University Credit: Pixabay/CC0 Public DomainCurtin University researchers have trialed an online nutrition education program designed to help people with multiple sclerosis (MS) manage their symptoms through healthy eating. “Eating Well with MS” was co-created with the MS community and provides a tailored approach to meet the specific needs of people...
Post
Multiple sclerosis progression linked to immune response outside the brain
JULY 23, 2024 by University of Southampton Credit: Brain Communications (2024). DOI: 10.1093/braincomms/fcae143New research, led by the University of Southampton and University Hospital Southampton, shows that inflammation outside the brain, such as that caused by common infections such as colds and urine infections, is linked to the progression of multiple sclerosis (MS). The Systemic Inflammation...
Post
How six ‘remarkable’ shots gave me my life back after doctors said nothing could treat my MS
By MAIYA FOCHT FOR DAILYMAIL.COM PUBLISHED: 07:31 EDT, 1 June 2024 | UPDATED: 07:51 EDT, 1 June 2024 When Robin Gordon-Cartier was first diagnosed with multiple sclerosis at 50 years old she felt like she was ‘just waiting to die.’ Her busy life as a harpist, full-time teacher and travelling performer was slowly eroding because...